1–1 of 1 result for Diabetes and vascular diseases
Interim Safety and Efficacy Results From the Phase 1 HELIOS Trial of Sustained-Release Axitinib Implant (OTX-TKI) for NPDR
Dilsher S. Dhoot, MD
Annual Meeting Talks
2024